Dr Lorcan McGarvey, Clinical Reader, from the Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast is undertaking a Phase IIa Respiratory Research Study at the NICRF.

TUSSIX: MT1-110 Tussix: is a randomised double-blinded, placebo-controlled study of the efficacy, safety and tolerability of serlopitant for the treatment of refractory chronic cough.

To learn more about the Study please read here.